FLIBANSERIN: ENHANCED PHARMACOVIGILANCE STUDY TO ASSESS AND ANALYZE THE RISKS OF ADVERSE EVENTS OF SPECIAL INTEREST Millheiser, L., Faragasso, A., Donatucci, S., Brown, L. ELSEVIER SCI LTD. 2020: S66

View details for DOI 10.1016/j.jsxm.2019.11.189

View details for Web of Science ID 000505047600134